The groundbreaking treatment of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Distinct from existing medications, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – leading to enhanced sugar management and potential weight loss. Scientists are studyi